Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Addiction (Abingdon, England)
|
January 30, 2019
The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England
Graham I Harrison, Karen Murray, Roxanne Gore, et al.
Wellcome Open Research
|
August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C
Graham S Cooke, Sarah Pett, Leanne McCabe, et al.
HIV Medicine
|
September 23, 2021
Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study)
Ming Jie Lee, Luke Blagdon Snell, Sam T Douthwaite, et al.
The New England Journal of Medicine
|
October 8, 2020
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
, Peter Horby, Marion Mafham, et al.
Lancet (London, England)
|
December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
Guy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Health Technology Assessment (Winchester, England)
|
November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT
Guy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
The Journal of Infection
|
June 4, 2026
Incidence, risk factors and management of paradoxical reaction in central nervous system tuberculosis in the United Kingdom
Emma C Carter, Cristina Fernandez, Charlotte Lim, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Addiction (Abingdon, England)
|
January 30, 2019
The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England
Graham I Harrison, Karen Murray, Roxanne Gore, et al.
Wellcome Open Research
|
August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C
Graham S Cooke, Sarah Pett, Leanne McCabe, et al.
HIV Medicine
|
September 23, 2021
Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study)
Ming Jie Lee, Luke Blagdon Snell, Sam T Douthwaite, et al.
The New England Journal of Medicine
|
October 8, 2020
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
, Peter Horby, Marion Mafham, et al.
Lancet (London, England)
|
December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
Guy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Health Technology Assessment (Winchester, England)
|
November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT
Guy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
The Journal of Infection
|
June 4, 2026
Incidence, risk factors and management of paradoxical reaction in central nervous system tuberculosis in the United Kingdom
Emma C Carter, Cristina Fernandez, Charlotte Lim, et al.
Page
of 4